Standard operating procedure

Size: px
Start display at page:

Download "Standard operating procedure"

Transcription

1 Standard operating procedure Title: Preparation and approval of new standard operating procedures Status: PUBLIC Document no.: SOP/EMA/0001 Approver Effective date:10-jul-2013 Name: Mario Benetti Name: Guido Rasi Review date:10-jul-2016 Signature: On file Signature: On file Supersedes: SOP/EMA/0001 (21-MAY-10) Date: 10-Jul-13 Date: 10-Jul-13 TrackWise record no.: Purpose To describe the procedure for developing a new standard operating procedure. An existing SOP should be revised according to the SOP on Review and revision of effective standard operating procedures (SOP/EMA/0013). 2. Scope This SOP applies to all lead authors involved in SOP/WIN drafting and to all Heads of Sector and Section Heads. 3. Responsibilities Each Head of Unit, Head of Sector and Section Head under the responsibility of the Executive Director must ensure that this procedure is adhered to within their own unit, sector or section. The responsibility for the execution of a particular part of this procedure is identified in the right-hand column of section Changes since last revision Revision of step 3 to adapt the instructions to the use of a MS Word SOP template instead of a template provided by TrackWise. Revision of step 4 to adapt the instruction with the use of MS Visio instead of MS Power Point to create flow charts. Replacement of references to EDMS by DREAM and updating of instructions to reflect DREAM. 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0) Facsimile +44 (0) info@ema.europa.eu Website An agency of the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.

2 5. Documents needed for this SOP SOP template in MS Word (provided solely by the ). Flow chart template in MS Visio (provided solely by the ). SOP_WIN transmission slip (provided solely by the ). 6. Related documents SOP/EMA/0037: Publication of, and training on standard operating procedures and work instructions WIN/EMA/0035: Creating and maintaining SOP/WIN folders in DREAM WIN/EMA/0036: Creating flow charts for standard operating procedures and work instructions WIN/EMA/0053: Use of TrackWise software for SOP/WIN recording and tracking 7. Definitions DREAM: Document records electronic archive management system EMA bodies: Management Board, scientific committees, working parties, scientific advisory groups, etc. of the European Medicines Agency HoS/SH: Head of Sector/Section Head : Unit IQM co-ordinator or delegate ManualCo: IQM manual co-ordinator or delegate SOP: Standard operating procedure - Detailed, written instructions to achieve uniformity of the performance of a specific procedure; the instructions usually cover more than one task or area within the Agency, Unit, or Sector TrackWise: Software for the tracking of processes and the creation and archiving of related records and associated documents. The SOP/WIN management module is intended for the recording and tracking of SOPs and WIN WIN: Work instructions Detailed descriptions of how to perform and record tasks; they may be, for example, detailed written descriptions, flow charts, checklists, pictures, or combinations thereof SOP/EMA/0001,10-Jul-13 Page 2/6

3 8. Process map(s)/ flow chart(s) START 1. Determine need for SOP Assign lead author Define scope and title Appoint drafting team Assign approver Determine consultation status and publication status 11. Announce on intranet news page 12. Evaluate and implement comments Check and finalise flow chart, SOP and related forms/templates Inform 2. Inform Unit IQM Co 13. Carry out QC check 3. Assign SOP Doc. No. Create e-folder structure (WIN/EMA/0035) Create TrackWise record (WIN/EMA/0053) Create SOP flow chart template (WIN/EMA/0036) Send to Lead author 4. Create flow chart (WIN/EMA/0036) 14. Implement corrections, if required 15. Update SOP status Print hard copy Update TrackWise record (WIN/EMA/0053) Generate transmission slip Categorise in activity area/type 5. Complete SOP Develop separate forms/ templates 16. Sign SOP (lead author) 6. Inform 17. Read and sign SOP (approver) 7. Check SOP format Update SOP status Update TrackWise record (WIN/EMA/0053) 18. Go to SOP/EMA/ Is consultation with EMA bodies required? END Yes No 9. Refer SOP to EMA bodies 10. Publish on IQM web page on intranet Inform intranet news editors SOP/EMA/0001,10-Jul-13 Page 3/6

4 9. Procedure Step Action Responsibility 1 Determine need for a new SOP. HoS/SH Assign lead author of SOP. Define scope, purpose and title of SOP with lead author. Appoint drafting team having a good knowledge of the procedure. If cross-section/sector/unit representation is necessary, consult with other SH/HoS to appoint team members. Determine who will be the approver of the SOP (Executive Director, HoU, HoS or SH). Determine the consultation status, i.e. whether the SOP will be made available only for internal EMA staff consultation or will be extended to other EMA bodies. Determine publication status of final SOP, i.e. PUBLIC or CONFIDENTIAL. Note: All documents should be PUBLIC (for publication on intranet and external web site). In case the document contains sensitive information, the document can be CONFIDENTIAL (for publication on intranet only). In case of difficulty with any part of this step, seek assistance of the. 2 Inform by of SOP title, consultation status, publication status, and lead author, drafting team and approver names. 3 Verify if any other SOP or WIN for similar procedures at the EMA exists or is under development to avoid duplication or divergence. If not, assign SOP document number and create SOP-specific folder in DREAM (refer to WIN/EMA/0035). Create new record in TrackWise (refer to WIN/EMA/0053). Create SOP and flow chart templates in DREAM (refer to WIN/EMA/0035). When completed, send to lead author with the link to the SOPspecific folder in DREAM.. 4 Prepare flow chart in MS Visio for the procedure to be documented (refer to WIN/EMA/0036) using the blank template provided by the. Save all versions of the document in the SOP-specific folder provided. 5 Complete SOP template provided by the. SOP/EMA/0001,10-Jul-13 Page 4/6

5 Step Action Responsibility Describe the procedure in clear and concise steps, based on the flow chart. Refer to documents required for the procedure, using the document title/number without version number, and provide details of their location (e.g. hyperlinked URL). Ensure that all functions identified as responsible for specific actions described in the SOP have been consulted and engaged in the drafting of the SOP. Paste the flow chart as a picture (enhanced metafile) in the SOP (refer to WIN/EMA/0036). Save all versions of the SOP in the SOP-specific folder provided. If the procedure described in the SOP requires the use of templates/forms, develop them in parallel to the SOP, NOT as appendices to the SOP. Refer to them in the SOP, and save the templates/forms in the SOPspecific folder. In case of difficulty with any part of this step, seek assistance of the. 6 When drafting is complete, inform the and discuss the required length of consultation. Note: For a new SOP, the length of consultation is 4 weeks; The period of consultation of EMA bodies may be longer than the standard 4 weeks (there is no maximum length in this case). 7 Check that SOP has been completed according to the instructions in the template and complete checklist in TrackWise (refer to WIN/EMA/0053). Update status of SOP to CONSULTATION (CONFIDENTIAL) in template and check in to DREAM. Update the TrackWise record (refer to WIN/EMA/0053) with the consultation details. Note: TrackWise sends automated notifications to lead author and ManualCo. 8 If the SOP requires consultation with EMA bodies, go to step 9. If the SOP does not require consultation with EMA bodies, go to step Refer SOP and forms/templates, if applicable, to secretariats of EMA bodies to initiate consultation. 10 Publish the SOP on the intranet IQM web page. ManualCo Inform the News Editors to advertise the SOP consultation on the intranet news page and provide the deadline for consultation. SOP/EMA/0001,10-Jul-13 Page 5/6

6 Step Action Responsibility 11 Announce SOP consultation on the intranet news page. Intranet news editors 12 On receipt of comments from staff and, where applicable, from EMA bodies, acknowledge receipt by . Evaluate comments and implement appropriate suggested improvements in the SOP. Check and finalise flow chart, SOP and forms/templates, if applicable. Inform when ready. Note: TrackWise sends automated notifications to lead author and at the end of the consultation and when there are delays in finalising a SOP after consultation. 13 Carry out quality check (use checklist in WIN/EMA/0053) and request lead author to make corrections, if required. 14 Make necessary corrections to SOP and forms/templates, if required. 15 Update status of SOP to agreed publication status as informed in step 2. Print hard copy. Check in to DREAM. Open the SOP record in TrackWise, document quality check and update required fields (refer to WIN/EMA/0053). Prepare the SOP_WIN transmission slip. Categorise the SOP in the relevant activity area and type for web publication, and document in the transmission slip. Forward SOP and transmission slip to lead author. 16 Sign SOP and transmission slip. Forward to approver. 17 Read SOP and sign SOP and transmission slip. Approver Forward to. 18 Refer to SOP/EMA/ Records Electronic records of SOPs are generated and saved in TrackWise. Electronic documents are filed, in DREAM under: Cabinets/06. Corporate governance/06.2 Integrated Management System/2. IMS Manual/5. SOPs and WINs SOP/EMA/0001,10-Jul-13 Page 6/6

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Review and revision of effective standard operating procedures Status: PUBLIC Document no.: SOP/EMA/0013 Approver Effective date: 10-Jul-13 Name: Mario Benetti Name:

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Review and revision of effective work instructions Status: PUBLIC Document no.: SOP/EMA/0034 Approver Effective date: 10-Jul-13 Name: Mario Benetti Name: Guido Rasi

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Audit programmes and internal audits conducted by the Audit Advisory Function Status: PUBLIC Document no.: SOP/EMA/0025 Lead author Approver Effective date: 29/07/2014

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: How to conduct a procurement procedure Status: PUBLIC Document no.: SOP/EMA/0121 Lead author Approver Effective date: 04.09.14 Name: Caroline Maignen Name: Stefano Marino

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Steps involved in outsourcing of services Status: PUBLIC Document no.: SOP/EMA/0083 Lead author Approver Effective date: 18-12-2014 Name: Caroline Maignen Name: Stefano

More information

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Title: How to create reports from scientific memory database (SMD)

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Title: How to create reports from scientific memory database (SMD) Work instructions Title: How to create reports from scientific memory database (SMD) Applies to: Clinical and Non-Clinical Compliance Section Status: PUBLIC Document no.: WIN/INSP/2040 Lead Author Approver

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Eligibility to the centralised procedure for medicinal products for human use Status: PUBLIC Document no.: SOP/H/3462 Lead author Approver Effective date: 05-FEB-16

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Evaluation procedure for eligibility of patients', consumers' and healthcare professionals organisations Status: Public Document no.: SOP/H/3390 Lead author Approver

More information

Questions and answers on post approval change management protocols

Questions and answers on post approval change management protocols 27 October 2010 EMA/CHMP/CVMP/QWP/586330/2010 Questions and answers on post approval change management protocols Draft Draft Agreed by QWP September 2010 Adoption by CHMP for release for consultation 23

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Handling invoice payment within deadline of 30 days (Standard Payments) Status: PUBLIC Document no.: SOP/EMA/0135 Lead author Approver Effective date: 18-FEB-2015 ame:

More information

All the steps detailed in this WIN are carried out by the assistant in the Sampling and Testing Team in the MQC Section.

All the steps detailed in this WIN are carried out by the assistant in the Sampling and Testing Team in the MQC Section. Work instructions Title: Sampling and testing of centrally authorised products - update of spreadsheet for the identification of the products to be tested on the basis of a risk assessment Applies to:

More information

Guidance for the format and content of the protocol of non-interventional post-authorisation safety studies

Guidance for the format and content of the protocol of non-interventional post-authorisation safety studies 26 September 2012 EMA/623947/2012 Patient Health Protection Guidance for the format and content of the protocol of non-interventional post-authorisation Introduction From 10 January 2013, marketing authorisation

More information

Questions and answers on post approval change management protocols

Questions and answers on post approval change management protocols 30 March 2012 EMA/CHMP/CVMP/QWP/586330/2010 Committee for Medicinal Products for Human Use (CHMP) Questions and answers on post approval change management protocols Draft agreed by CHMP / CVMP Quality

More information

EU Clinical Trials Register. www.clinicaltrialsregister.eu. An agency of the European Union

EU Clinical Trials Register. www.clinicaltrialsregister.eu. An agency of the European Union EU Clinical Trials Register www.clinicaltrialsregister.eu An agency of the European Union The EU Clinical Trials Register provides public access to information from the European Union (EU) clinical trial

More information

End of consultation (deadline for comments) 14 October 2009. Adoption by Committee for advanced therapies 15 October 2010

End of consultation (deadline for comments) 14 October 2009. Adoption by Committee for advanced therapies 15 October 2010 15 October 2010 EMA/CAT/418458/2008/corr. Committee for advanced therapies (CAT) Procedural advice on the certification of quality and nonclinical data for small and medium sized enterprises developing

More information

XML Conversion Utility User Awareness

XML Conversion Utility User Awareness 8 March 2011 Topics Prerequisites What you do Know Issues Prerequisites: Note: EudraCT Version 8 has a more comprehensive set of field validation to ensure data completeness and consistency that EudraCT

More information

Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials

Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials 1 2 3 5 August 2011 EMA/INS/GCP/600788/2011 Compliance and Inspection 4 5 6 7 Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials

More information

EMA esignature capabilities: frequently asked questions relating to practical and technical aspects of the implementation

EMA esignature capabilities: frequently asked questions relating to practical and technical aspects of the implementation August 2013 EMA/264709/2013 EMA esignature capabilities: frequently asked questions relating to practical and technical aspects of the implementation This question and answer document aims to address the

More information

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions EXPLANATORY NOTES

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions EXPLANATORY NOTES Work instructions Title: Calculation of fees for GMP and product related inspections Applies to: P-CI-MQC staff Status: PUBLIC Document no.: WIN/INSP/2043 Lead Author Approver Effective Date: 13-APR-12

More information

Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials

Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials 09 June 2010 EMA/INS/GCP/454280/2010 GCP Inspectors Working Group (GCP IWG) Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 17 July 2006 Doc. Ref. EMEA/419127/05 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PROCEDURE

More information

Annex VI Service Level Agreement for Medical Service Provider

Annex VI Service Level Agreement for Medical Service Provider Annex VI Service Level Agreement for Medical Service Provider The term medical service provider referred to in this document is the contractor with which the Agencies i.e. EMA, EBA and CEPOL have signed

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration

More information

European Medicines Agency decision

European Medicines Agency decision EMA/650134/2010 European Medicines Agency decision P/202/2010 of 27 October 2010 on the acceptance of a modification of an agreed paediatric investigation plan for propranolol hydrochloride, (EMEA-000511-PIP01-08-M02)

More information

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group

PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197228/2005 Procedure no.: INS/GCP/2 PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA GCP Inspectors Working Group

More information

Distant/virtual pharmacovigilance inspections of MAHs during a crisis situation- Points to consider

Distant/virtual pharmacovigilance inspections of MAHs during a crisis situation- Points to consider 18 January 2013 EMA/INS/119905/2012 Compliance and Inspection Distant/virtual pharmacovigilance inspections of MAHs during a crisis situation- Points This document is intended to provide guidance on the

More information

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012 10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular

More information

Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples

Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples 28 February 2012 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group Reflection paper for laboratories that perform the analysis or evaluation of clinical trial Draft agreed by GCP Inspectors Working

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Evaluation of Medicines for Human Use London, 19 July 2007 Doc. Ref: EMEA/27170/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON COMPASSIONATE USE OF MEDICINAL

More information

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

More information

Compilation of Community Procedures on Inspections and Exchange of Information

Compilation of Community Procedures on Inspections and Exchange of Information EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE- GENERAL Public Health and Risk Assessment Pharmaceuticals 27 June 2013 EMA/385898/2013 Rev 16 Compliance and Inspection Compilation of Community

More information

Questions and answers relating to Open Procedure EMA 2012-37-ED Online Strategy and Interface Design

Questions and answers relating to Open Procedure EMA 2012-37-ED Online Strategy and Interface Design 27 June 2013 EMA/352562/2013 Questions and answers relating to Open Procedure EMA 2012-37-ED Online Strategy and Interface Design Table of contents Questions and answers... 2 Document history... 6 7 Westferry

More information

Draft Agreed by Pharmacokinetics Working Party January 2011. End of consultation (deadline for comments) 31 May 2011

Draft Agreed by Pharmacokinetics Working Party January 2011. End of consultation (deadline for comments) 31 May 2011 1 2 3 17 February 2011 EMA/CHMP/600958/2010 Committee of Medicines for Human Use (CHMP) 4 5 6 7 8 Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 Rev.1): Presentation

More information

Questions and answers relating to Restricted tender procedure EMA/2012/19/IS Provision of Security Consultancy Services

Questions and answers relating to Restricted tender procedure EMA/2012/19/IS Provision of Security Consultancy Services 30 October 2012 EMA/702274/2012 Questions and answers relating to Restricted tender procedure EMA/2012/19/IS Provision of Security Consultancy Services Table of contents Questions and answers... 2 Document

More information

EMA esubmission Gateway: Questions and answers relating to practical and technical aspects of the implementation

EMA esubmission Gateway: Questions and answers relating to practical and technical aspects of the implementation 28 February 2014 EMA/609325/2011 EMA esubmission Gateway: Questions and answers relating to practical and technical aspects of the implementation This question and answer document aims to address the commonly-asked

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/CVMP/044/99-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) European Medicines Agency Veterinary Medicines and Inspections London, 18 May 2006 Doc. Ref. EMEA/CVMP/32995/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON THE PROCEDURE FOR

More information

Questions & answers on signal management

Questions & answers on signal management 23 October 2015 EMA/261758/2013 Inspections and Human Medicines Pharmacovigilance Division This document addresses a number of questions which stakeholders, in particular marketing authorisation holders

More information

EU PAS Register Guide

EU PAS Register Guide 29 March 2016 EMA/613603/2012 (currently ENCePP E-Register of Studies) The EU PAS Register is temporarily hosted on the ENCePP website www.encepp.eu 1. Introduction... 2 2. ENCePP E-Register as a temporary

More information

Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1)

Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1) 22 May 2014 EMA/CHMP/BWP/247713/2012 Committee for Medicinal Products for Human Use (CHMP) Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance:

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 22 June 2012 EMA/541760/2011 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration with Member

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DATA MONITORING COMMITTEES

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DATA MONITORING COMMITTEES European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 27 July 2005 Doc. Ref. EMEA/CHMP/EWP/5872/03 Corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

Quick Response (QR) codes in the labelling and package leaflet of centrally authorised 1 medicinal products

Quick Response (QR) codes in the labelling and package leaflet of centrally authorised 1 medicinal products 22 July 2015 EMA/493897/2015 Human Medicines Evaluation Division Quick Response (QR) codes in the labelling and package leaflet of centrally authorised 1 medicinal General principles of acceptability and

More information

Draft agreed by Pharmacokinetics Working Party January 2011. Adoption by CHMP for release for consultation 17 February 2011

Draft agreed by Pharmacokinetics Working Party January 2011. Adoption by CHMP for release for consultation 17 February 2011 17 November 2011 EMA/CHMP/600958/2010/Corr.* Committee of Medicines for Human Use (CHMP) Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 Rev.1): Presentation of

More information

Submission of comments on 'Policy 0070 on publication and access to clinical-trial data'

Submission of comments on 'Policy 0070 on publication and access to clinical-trial data' EMA/240810/2013 Submission of comments on 'Policy 0070 on publication and access to clinical-trial data' s from: Name and affiliation PHARMIG - Association of the Austrian pharmaceutical industry Please

More information

SP007 - Procedure for the Control of Documents & Data

SP007 - Procedure for the Control of Documents & Data 1.1 SCOPE: SP007 - Procedure for the Control of Documents & Data In conformance with the requirements of ISO 9001:2008, document, data control is essential for the overall efficiency and quality of London

More information

CMDv/BPG/001. BEST PRACTICE GUIDE for Veterinary Mutual Recognition Procedure (MRP) Edition 04. Edition date: 19 July 2013

CMDv/BPG/001. BEST PRACTICE GUIDE for Veterinary Mutual Recognition Procedure (MRP) Edition 04. Edition date: 19 July 2013 EMA/CMDv/83618/2006 BEST PRACTICE GUIDE for Veterinary Mutual Recognition Procedure (MRP) Edition 04 Edition date: 19 July 2013 Implementation date: 23 November 2006 CMDv Secretariat: European Medicines

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: SOP number: SOP category: Document Control GE-003 General SOP history Version number: 01 Version date: 1 March 2013 Effective

More information

Regulatory approval routes in the European System for Medicinal Products

Regulatory approval routes in the European System for Medicinal Products Regulatory approval routes in the European System for Medicinal Products Cardiovascular Combination Pharmacotherapy Global Summit, Melbourne, 8 th May 2014 Presented by: Kevin Blake Human Medicines Research

More information

Reflection paper on clinical aspects related to tissue engineered products

Reflection paper on clinical aspects related to tissue engineered products 1 2 3 19 March 2012 EMA/CAT/CPWP/573420/2009 Committee for Advanced Therapies (CAT) 4 5 6 Reflection paper on clinical aspects related to tissue engineered products Draft Draft agreed by CPWP 7 October

More information

GUIDANCE for Administration of the Sunset Clause

GUIDANCE for Administration of the Sunset Clause GUIDANCE Edition number : 02 Edition date: 16/07/2010 Implementation date : 28/12/2007 CMDv Secretariat: 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK CMDv/TEM/013-00 Tel. (44-20) 74 18 84 00 Fax.

More information

Guideline on Detection and Management of Duplicate Individual Cases and Individual Case Safety Reports (ICSRs)

Guideline on Detection and Management of Duplicate Individual Cases and Individual Case Safety Reports (ICSRs) London, 21 April 2009 Doc. Ref. EMA/13432/2009 Committee for Medicinal Products for Human Use (CHMP) Guideline on Detection and Management of Duplicate Individual Cases and Individual Case Safety Reports

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP) European Medicines Agency Veterinary Medicines and Inspections London, 15 April 2005 EMEA/CVMP/134/02 Rev 1 CPMP/QWP/227/02 Rev 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY

More information

Guideline on Process Validation

Guideline on Process Validation 1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /

More information

The Clinical Trials Regulation EU No 536/2014: and Phase I trials

The Clinical Trials Regulation EU No 536/2014: and Phase I trials The Clinical Trials Regulation EU No 536/2014: and Phase I trials EUFEMED, Brussels, 20 May 2015 Presented by Fergus Sweeney Head, Inspections and Human Medicines Pharmacovigilance An agency of the European

More information

Communications Policy

Communications Policy ethekwini Municipality Communications Unit Communications Policy (As adopted by Council on 29.4.09) Basement Phone 27 31 311 2279 City Hall Fax 27 31 3064603 West Street Durban 4001 email: magwazantsiki@durban.gov.za

More information

Managing & Validating Research Data

Managing & Validating Research Data Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical

More information

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials 1 2 3 15 June 2015 EMA/INS/GCP/636736/2012 Good Clinical Practice Inspectors Working Group (GCP IWG) 4 5 6 7 Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic)

More information

Strategy and pilot phase for patient registries

Strategy and pilot phase for patient registries Strategy and pilot phase for patient registries Draft still under discussion Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015 Xavier Kurz, Head of Monitoring

More information

Questions and answers relating to Open Tender EMA/2012/21/IS

Questions and answers relating to Open Tender EMA/2012/21/IS 12 December 2012 EMA/748793/2012 Table of contents Questions and answers... 2 Document history... 7 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile

More information

Video surveillance policy (PUBLIC)

Video surveillance policy (PUBLIC) 29 July 2015 EMA/133708/2015 Administration Division POLICY/0046 POLICY/0046 Effective Date: 01/01/2015 Review Date: 01/01/2018 Supersedes: Version 1 1. Introduction and purpose For the safety and security

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure Title: Production and Control of Standard Operating Procedures Purpose The purpose of this SOP is to describe the procedure to be followed to ensure that SOPs are produced

More information

Adoption by CHMP for release for consultation November 2010. End of consultation (deadline for comments) 31 March 2011

Adoption by CHMP for release for consultation November 2010. End of consultation (deadline for comments) 31 March 2011 1 2 3 November 2010 EMA/759784/2010 Committee for Medicinal Products for Human Use 4 5 6 7 Reflection paper on the need for active control in therapeutic areas where use of placebo is deemed ethical and

More information

Procurement Guide. 3.1.12.2 Once you have found the required document, double click and it will upload onto the screen.

Procurement Guide. 3.1.12.2 Once you have found the required document, double click and it will upload onto the screen. 3.1.12 If you need to attach quotes, emails or other documents to the purchase order to adhere to the purchasing delegations and enable the release of the order, click on the Attachments option, which

More information

EMA pharmacovigilance system manual

EMA pharmacovigilance system manual 30 June 2014 EMA/623550/2013 Inspections and Human Medicines Pharmacovigilance Division Version 1.1 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile

More information

Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency 28 August 2015 EMA/386784/2015 Inspections and Human Medicines Pharmacovigilance Division Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the

More information

BEST PRACTICE GUIDE for Handling of Periodic Safety Update Reports

BEST PRACTICE GUIDE for Handling of Periodic Safety Update Reports EMEA/CMDv/408477/2007 12 March 2009 BEST PRACTICE GUIDE for Handling of Periodic Safety Update Reports Edition number : 00 Edition date: 12 March 2009 Implementation date : 27 March 2009 CMD(v) Secretariat:

More information

Draft agreed by the QWP February 2015. Draft adopted by the CHMP for release for consultation March 2015. Draft endorsed by the CMD(h) March 2015

Draft agreed by the QWP February 2015. Draft adopted by the CHMP for release for consultation March 2015. Draft endorsed by the CMD(h) March 2015 1 2 3 26 March 2015 EMA/CHMP/QWP/104223/2015 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on the chemical structure and properties criteria to be considered for the evaluation

More information

One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency

One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency 8 April 2014 EMA/171322/2014 Pharmacovigilance Department One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency Reporting period: 2 July 2012 to 1 July 2013 7 Westferry

More information

IMPORTANT DOCUMENT INVITATION TO NEGOTIATE REVISION. OPENING DATE & TIME: February 11, 2014 @ 2:00 PM ADDENDUM NUMBER: 2 ADDENDUM DATE: 1/17/2014

IMPORTANT DOCUMENT INVITATION TO NEGOTIATE REVISION. OPENING DATE & TIME: February 11, 2014 @ 2:00 PM ADDENDUM NUMBER: 2 ADDENDUM DATE: 1/17/2014 IMPORTANT DOCUMENT INVITATION TO NEGOTIATE REVISION ITN NUMBER: 1307CCSA OPENING DATE & TIME: February 11, 2014 @ 2:00 PM ITN TITLE: Contract Management Database ADDENDUM NUMBER: 2 ADDENDUM DATE: 1/17/2014

More information

Frequently Asked Questions - Trainees at the EMA

Frequently Asked Questions - Trainees at the EMA 09 May 2016 EMA/298474/2016 Administration Content 1. Applying for a traineeship at the Agency... 1 2. Practical information about London... 2 3. Your first day at the Agency... 3 4. Being a trainee at

More information

EMA/AD/350: Scientific Administrator, Quality of Medicines, Human Medicines Development and Evaluation Unit (AD6)

EMA/AD/350: Scientific Administrator, Quality of Medicines, Human Medicines Development and Evaluation Unit (AD6) 12 June 2013 EMA/270563/2013 Administration EMA/AD/350: Scientific Administrator, Quality of Medicines, Human Medicines Development and Evaluation Unit (AD6) The Agency is looking to recruit a competent

More information

Table of Contents. Chapter No. 1. Introduction 1. 2. Objective 1. 3. E-mail Use Compliance 1. 4. Definitions 2. 5. Roles and Responsibilities 2

Table of Contents. Chapter No. 1. Introduction 1. 2. Objective 1. 3. E-mail Use Compliance 1. 4. Definitions 2. 5. Roles and Responsibilities 2 Table of Contents Chapter Subject Page No. 1. Introduction 1 2. Objective 1 3. E-mail Use Compliance 1 4. Definitions 2 5. Roles and Responsibilities 2 6. Creation and Use of E-mails 3 7. Managing E-mails

More information

How to search the EU Clinical Trials Register

How to search the EU Clinical Trials Register 28 April 2014 Information and Communications Technology Contents Contents... 1 1. Searching the EU Clinical Trials Register... 1 1.1. Basic search... 2 1.2. Search for multiple words (AND operator)...

More information

QRD recommendations on pack design and labelling for centrally authorised non-prescription human medicinal products

QRD recommendations on pack design and labelling for centrally authorised non-prescription human medicinal products 1 2 3 10 March 2011 Quality Review Documents (QRD) 4 5 6 7 QRD recommendations on pack design and labelling for centrally authorised non-prescription human medicinal products Draft Draft Agreed by Quality

More information

Guideline on stability testing for applications for variations to a marketing authorisation

Guideline on stability testing for applications for variations to a marketing authorisation 21 March 2014 EMA/CHMP/CVMP/QWP/441071/2011- Rev.2 Committee for Medicinal Products for Human Use (CHMP)/ Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on stability testing for applications

More information

Compilation of Community Procedures on Inspections and Exchange of Information

Compilation of Community Procedures on Inspections and Exchange of Information EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE- GENERAL Public Health and Risk Assessment Pharmaceuticals 3 October 2014 EMA/572454/2014 Rev 17 Compliance and Inspection Compilation of Community

More information

ACADEMIC POLICY FRAMEWORK

ACADEMIC POLICY FRAMEWORK ACADEMIC POLICY FRAMEWORK Principles, Procedures and Guidance for the Development & Review of Academic Policies [V.1] Page 2 of 11 TABLE OF CONTENTS 1. FRAMEWORK OVERVIEW... 3 2. PRINCIPLES... 4 3. PROCESS...

More information

Vendor Access Management

Vendor Access Management Vendor Access Management ProPath Office of Information and Technology Table of Contents Vendor Access Management Process Map... 1 Process: Vendor Access Management... 2 Vendor Access Management Description

More information

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS

More information

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,

More information

Technical specifications for open invitation to tender

Technical specifications for open invitation to tender 7 June 2013 EMA/680395/2012 No. EMA 2012-37-ED: Online strategy and interface design Table of contents 1. Title of the invitation to tender... 3 2. Objectives and context of the invitation to tender...

More information

Montgomery County Public Schools. Financial Management System (FMS) User s Guide. iexpense. Version 3.0. May 2013. Division of Controller

Montgomery County Public Schools. Financial Management System (FMS) User s Guide. iexpense. Version 3.0. May 2013. Division of Controller Montgomery County Public Schools Financial Management System (FMS) User s Guide iexpense Version 3.0 May 2013 Division of Controller Copyright and Trademarks Copyright Montgomery County Public Schools,

More information

BEST PRACTICE GUIDE 3: TENDER PROCESSES AND TENDER DOCUMENTS. RDTL MINISTRY OF FINANCE Procurement Service

BEST PRACTICE GUIDE 3: TENDER PROCESSES AND TENDER DOCUMENTS. RDTL MINISTRY OF FINANCE Procurement Service RDTL MINISTRY OF FINANCE Procurement Service BEST PRACTICE GUIDE 3: TENDER PROCESSES AND TENDER DOCUMENTS 1 RDTL Procurement Guidelines The Procurement Legal Regime Decree Law sets out new procurement

More information

American Podiatric Medical Students Association (APMSA) Research Grant Program ANNOUNCEMENT FOR 2015-2016 GENERAL INFORMATION

American Podiatric Medical Students Association (APMSA) Research Grant Program ANNOUNCEMENT FOR 2015-2016 GENERAL INFORMATION American Podiatric Medical Students Association (APMSA) Research Grant Program Generously sponsored in part by the APMSA Partners Program. The APMSA Partners program provides a means to demonstrate commitment

More information

DRAFT REVISED READINESS CHECKLISTS

DRAFT REVISED READINESS CHECKLISTS DRAFT REVISED READINESS CHECKLISTS OVERVIEW The Readiness Checklists are lists of expectations for any health department that is preparing to apply for public health department accreditation. The Checklists

More information

Draft agreed by the QWP February 2015. Draft adopted by the CHMP for release for consultation March 2015. Draft endorsed by the CMD(h) March 2015

Draft agreed by the QWP February 2015. Draft adopted by the CHMP for release for consultation March 2015. Draft endorsed by the CMD(h) March 2015 17 December 2015 EMA/CHMP/QWP/104223/2015 Committee for Medicinal Products for Human Use (CHMP) Reflection paper on the chemical structure and properties criteria to be considered for the evaluation of

More information

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name

More information

MYOB Document Manager

MYOB Document Manager MYOB Document Manager Version 4.0 User Guide Copyright 2009 MYOB Technology Pty Ltd. All rights reserved. Disclaimer MYOB has made every attempt to ensure the accuracy, relevance and completeness of this

More information

Submission of comments on 'Policy 0070 on publication and access to clinical-trial data'

Submission of comments on 'Policy 0070 on publication and access to clinical-trial data' EMA/240810/2013 Submission of comments on 'Policy 0070 on publication and access to clinical-trial data' s from: Name and affiliation For the Austrian Medicines & Medical Devices Agency (AGES), Austria,

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 9 April 2013 EMA/816573/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module II Pharmacovigilance system master file (Rev 1) Draft of first version finalised by the Agency in collaboration

More information

Appointing a primary school principal

Appointing a primary school principal Contents Preparation and planning... 1 Role description and person specification...1 Appointment committee s role...1 Important aspects of appointment process...2 The process... 2 Advertising and receiving

More information

Audits must be conducted with due concern for employee safety and environmental protection.

Audits must be conducted with due concern for employee safety and environmental protection. Standard Operating Procedure Title: GMP Audit Procedure Related Documents TEM-080 Internal Audit Report Template TEM-120 Vendor Audit Report Template Form-385 Vendor Audit Questionnaire Form-445 EHS Workplace

More information

COMPLETED EXAMPLE PMM Interactive Flow

COMPLETED EXAMPLE PMM Interactive Flow COMPLETED EXAMPLE PMM Interactive Flow Project Charge Document (M101) 1. Project Information Project Name: PMM Interactive Flow PlanView Number: Project Sponsor: Project Size: Project Director: Project

More information

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December

More information

Customer Portal User Guide: Transition to Delegation

Customer Portal User Guide: Transition to Delegation NEW GTLD PROGRAM Customer Portal User Guide: Transition to Delegation Version 0.8 Table of Contents About this User Guide... 2 Introduction to the Customer Portal... 3 Logging in with your User Name and

More information

II. AREA OF INVOLVEMENT OF PATIENTS AND CONSUMERS IN EMEA ACTIVITIES

II. AREA OF INVOLVEMENT OF PATIENTS AND CONSUMERS IN EMEA ACTIVITIES European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use MINUTES OF THE EIGHTH MEETING OF THE EMEA HUMAN SCIENTIFIC COMMITTEES WORKING PARTY WITH PATIENTS' AND CONSUMERS' ORGANISATIONS

More information

POST-AUTHORISATION GUIDANCE. Human Medicinal Products

POST-AUTHORISATION GUIDANCE. Human Medicinal Products European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use London, 23 February 2006 Doc. Ref. EMEA/180079/2005 POST-AUTHORISATION GUIDANCE Human Medicinal Products QUESTIONS AND

More information

EudraVigilance stakeholder change management plan

EudraVigilance stakeholder change management plan 26 October 2015 EMA/797114/2014 Information Management Division Consultation of Project Maintenance Group 1 15 July 2015 Consultation of Eudravigilance Expert Working Group 23 September 2015 Consultation

More information